This excerpt taken from the NVS 6-K filed Feb 8, 2008.
Excedrin and expansion in emerging markets, including Eastern Europe and Russia. Rapid growth in Japan following entry in 2007 into the worlds second-largest OTC market. Maintains position as worlds fourth-largest OTC company.
Animal Health, ranked No. 5 in its industry, benefits from solid performances in Europe, Asia-Pacific and Latin America. Sankyo Lifetech acquisition in Japan strengthens presence in companion-animal segment.
CIBA Vision successfully addresses production challenges for lens-care and contact lens products.